Skip to main content
Varietly

Verified provider profile

Hims & Hers

Publicly traded (NASDAQ: HIMS) telehealth prescriber that discontinued compounded GLP-1s in 2026, now exclusively prescribing brand-name Wegovy via a Novo Nordisk direct partnership.

Semaglutide (brand Wegovy oral) per month
$149–$299
Semaglutide (brand Wegovy injectable) per month
$199–$349
Semaglutide (brand Ozempic) per month
$199
Tirzepatide (brand Mounjaro) per month
$1,899
Tirzepatide (brand Zepbound) per month
$1,899
Liraglutide (generic) per month
$299
Typical turnaround
Not assessed
Compounding
Brand only
Check current price at Hims & Hers

Plans

Semaglutide (brand Wegovy oral)

Membership $149/mo · onboarding $0 · labs not included · coaching included

Applies to every option below.

Semaglutide (brand Wegovy injectable)

Semaglutide (brand Ozempic)

Membership access — medication billed separately

  • Hims & Hers Weight Loss Membership

    Not published/mo medication

    Membership access — medication billed separately · All

    Membership $149/mo · onboarding $0 · labs not included · coaching included

    Standard $149/mo; first month promo $39. Includes 24/7 care team, nutrition guidance, peer support. Labs not included. HSA/FSA accepted. NEEDS RE-CHECK (2026-09-10): live hims.com pricing cards for Wegovy pill/pen, Ozempic, Mounjaro, Zepbound, and Generic Liraglutide all show standalone "starting at $X/mo" headline prices with no visible membership add-on at that funnel stage. Whether this $149/mo membership is still required, optional, or folded into the medication price shown is unconfirmed.

    Source: Hims & Hers – investor relations: Strategic Shift for US Weight Loss Business (2026)

Tirzepatide (brand Mounjaro)

Tirzepatide (brand Zepbound)

Liraglutide (generic)

Fulfillment

NovoCare Pharmacy (Novo Nordisk)